Category: Press Releases
The Longevity Biotech Fellowship Bottleneck Survey
December 6, 2023
The LBF community is dedicated to maximally accelerating progress in longevity. While the field has seen substantial advances in the past decade, there are clear and systemic deficiencies that have
JellyfishDAO to Create Longevity Films and Television
December 6, 2023
A group of award-winning filmmakers, longevity experts, and blockchain developers have come together to launch JellyfishDAO, a new decentralized autonomous organization (DAO) focused on funding and distributing movies and TV
Vitalia: A “Los Alamos” for Longevity Starting in Roatán
December 4, 2023
Vitalia is a new venture that aims to redefine the longevity biotech landscape, fostering drug development at warp speed: 4 months to get to market, instead of 10+ years. From
Rejuve’s Longevity App Welcomes Peptide Bioregulator
November 2, 2023
‘Longevity’, an app designed to empower everyone to live longer, healthier lives, welcomes its latest partner, Peptide Bioregulator, a high quality supplement company. The app, featuring top-tier partners in supplements, wearables,
BioAge Labs Announces Plans for Phase 2 Trial of BGE-105
October 26, 2023
BioAge Labs, Inc., (“BioAge”), a clinical-stage biotechnology company developing therapeutics that target the molecular causes of aging to extend healthy human lifespan, today announced plans to initiate a Phase 2
Turn Bio on Track to Have First Cell Rejuvenation in Clinic
October 25, 2023
Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines for untreatable, age-related conditions, received positive feedback during an FDA Initial Targeted Engagement for Regulatory Advice on CBER producTs (INTERACT)
GenAI Biotech Gero Raises $6M to Find Root Causes of Aging
October 23, 2023
Gero, a biotechnology company focused on aging and chronic diseases, has closed $6M in a Series A extension round. This funding round positions Gero to continue internal drug development programs,
VitaDAO Approves Launch and Financing of Biotech Company
October 6, 2023
VitaDAO, the global online community driving early-stage longevity research through innovative funding collaborations announced today the launch of its very first biotech company, Matrix Biosciences. This significant milestone comes from
SENS Research Foundation Returns with Ending Aging Forum
September 14, 2023
It is not long before the SENS Research Foundation (SRF) hosts its second Ending Aging Forum! It will be happening next week, September 21st and 22nd, at 9 AM to
Singapore Opens World’s First Healthy Longevity Clinic
August 31, 2023
The National University Health System, National University of Singapore and Alexandra Hospital have launched the world’s first Healthy Longevity Clinic in a public hospital to increase Singaporeans’ healthspan by three
VitaDAO Launches VITA-FAST Tokens
July 4, 2023
VitaDAO, the global community accelerating research and development in longevity science, is pleased to announce the launch of the VITA-FAST tokens. This marks the first-ever opportunity for token holders to
Chris Hemsworth’s Centr Partners with lifespan.io
June 20, 2023
We are thrilled to announce a new partnership with Centr to provide its community with world-class expertise on longevity. The official press release follows. Centr, a health and wellness
Dr. David Sinclair Assumes Presidency of the AHLR
June 15, 2023
New York, June 14th, 2023 – The Academy for Health and Lifespan Research (AHLR) is proud to announce the election of Dr. David Sinclair as its new President. Dr. Sinclair,
The SynBioBeta Conference is Almost Here
May 10, 2023
At Oakland Marriott, California May 23-25, the SynBioBeta Global Synthetic Biology Conference is happening. This is a three-day event featuring industry thought leaders speaking sessions, exhibitors with hands-on product
Life Biosciences Claims Visual Restoration in Primates
April 26, 2023
Life Biosciences, a company co-founded by the well-known Dr. David Sinclair, has recently claimed that it has reversed a form of neuropathy in nonhuman primates through gene therapy and epigenetic
The Longevity Biotech Fellowship Bottleneck Survey
December 6, 2023
The LBF community is dedicated to maximally accelerating progress in longevity. While the field has seen substantial advances in the past decade, there are clear and systemic deficiencies that have received little attention but retard progress for many. To coordinate efforts and identify the highest leverage
JellyfishDAO to Create Longevity Films and Television
December 6, 2023
A group of award-winning filmmakers, longevity experts, and blockchain developers have come together to launch JellyfishDAO, a new decentralized autonomous organization (DAO) focused on funding and distributing movies and TV shows related to extending health and lifespan. “We created JellyfishDAO to shift the narrative around longevity
Vitalia: A “Los Alamos” for Longevity Starting in Roatán
December 4, 2023
Vitalia is a new venture that aims to redefine the longevity biotech landscape, fostering drug development at warp speed: 4 months to get to market, instead of 10+ years. From January 6 to March 1, Vitalia will be hosting a two-month pop-up city experience similar to
Rejuve’s Longevity App Welcomes Peptide Bioregulator
November 2, 2023
‘Longevity’, an app designed to empower everyone to live longer, healthier lives, welcomes its latest partner, Peptide Bioregulator, a high quality supplement company. The app, featuring top-tier partners in supplements, wearables, testing, DNA sequencing, and epigenetics, will leverage AI, cutting-edge research, and blockchain technology to democratise access
BioAge Labs Announces Plans for Phase 2 Trial of BGE-105
October 26, 2023
BioAge Labs, Inc., (“BioAge”), a clinical-stage biotechnology company developing therapeutics that target the molecular causes of aging to extend healthy human lifespan, today announced plans to initiate a Phase 2 trial of its oral apelin receptor agonist BGE-105 (azelaprag) co-administered with the GLP-1/GIP receptor agonist tirzepatide
Turn Bio on Track to Have First Cell Rejuvenation in Clinic
October 25, 2023
Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines for untreatable, age-related conditions, received positive feedback during an FDA Initial Targeted Engagement for Regulatory Advice on CBER producTs (INTERACT) meeting to review progress and plans for its therapeutic treatment to rejuvenate skin cells. The meeting
GenAI Biotech Gero Raises $6M to Find Root Causes of Aging
October 23, 2023
Gero, a biotechnology company focused on aging and chronic diseases, has closed $6M in a Series A extension round. This funding round positions Gero to continue internal drug development programs, grow its scientific team to boost platform technology development, and expand its US presence. The round
VitaDAO Approves Launch and Financing of Biotech Company
October 6, 2023
VitaDAO, the global online community driving early-stage longevity research through innovative funding collaborations announced today the launch of its very first biotech company, Matrix Biosciences. This significant milestone comes from a community-wide vote and approval in favor of a collaboration with Vera Gorbunova, Ph.D., Co-Chair of
SENS Research Foundation Returns with Ending Aging Forum
September 14, 2023
It is not long before the SENS Research Foundation (SRF) hosts its second Ending Aging Forum! It will be happening next week, September 21st and 22nd, at 9 AM to 1 PM Pacific Time. The event is a great opportunity to catch up with SRF’s team
Singapore Opens World’s First Healthy Longevity Clinic
August 31, 2023
The National University Health System, National University of Singapore and Alexandra Hospital have launched the world’s first Healthy Longevity Clinic in a public hospital to increase Singaporeans’ healthspan by three years in the next ten years. The Healthy Longevity Clinic at Alexandra Hospital translates healthy longevity
VitaDAO Launches VITA-FAST Tokens
July 4, 2023
VitaDAO, the global community accelerating research and development in longevity science, is pleased to announce the launch of the VITA-FAST tokens. This marks the first-ever opportunity for token holders to directly influence longevity research, setting a new precedent in the field of decentralized science (DeSci). The
Chris Hemsworth’s Centr Partners with lifespan.io
June 20, 2023
We are thrilled to announce a new partnership with Centr to provide its community with world-class expertise on longevity. The official press release follows. Centr, a health and wellness ecosystem founded by Chris Hemsworth, today announced an all-new partnership with lifespan.io, a 501(c)(3) foundation whose mission
Dr. David Sinclair Assumes Presidency of the AHLR
June 15, 2023
New York, June 14th, 2023 – The Academy for Health and Lifespan Research (AHLR) is proud to announce the election of Dr. David Sinclair as its new President. Dr. Sinclair, a distinguished Professor of Genetics at Harvard Medical School and renowned author of the New York
The SynBioBeta Conference is Almost Here
May 10, 2023
At Oakland Marriott, California May 23-25, the SynBioBeta Global Synthetic Biology Conference is happening. This is a three-day event featuring industry thought leaders speaking sessions, exhibitors with hands-on product demos, and focused industry networking opportunities. Global entrepreneurs, academics, investors, and policymakers attend SynBioBeta to connect,
Life Biosciences Claims Visual Restoration in Primates
April 26, 2023
Life Biosciences, a company co-founded by the well-known Dr. David Sinclair, has recently claimed that it has reversed a form of neuropathy in nonhuman primates through gene therapy and epigenetic reprogramming. The full press release is included here. Life Biosciences, a biotechnology company advancing innovative cellular